Diuretics for cardiovascular prevention in the elderly

被引:0
|
作者
O Hanon
M-L Seux
H Lenoir
A-S Rigaud
X Girerd
F Forette
机构
[1] Hôpital Broca,Department of Geriatrics
[2] Hôpital de la Pitié Salpêtrière,Department of Endocrinology—Cardiovascular Prevention Unit
来源
Journal of Human Hypertension | 2004年 / 18卷
关键词
diuretics; cardiovascular prevention; elderly;
D O I
暂无
中图分类号
学科分类号
摘要
High blood pressure (BP) is a major risk factor for cardiovascular and cerebrovascular diseases in elderly subjects. Antihypertensive drugs have shown clinical benefit both in primary and secondary prevention of cardiovascular events. If BP lowering represents the major determinant of the effects conferred by the antihypertensive treatment for prevention, recent studies have suggested some differences between classes of antihypertensive drugs according to age. Based on the available clinical data, the recent medical guidelines have recommended thiazide-type diuretics as the preferred drug for the treatment of elderly hypertensive patients, followed by long-acting calcium antagonists. Indeed, diuretics constitute one of the most valuable classes of antihypertensive drugs, and in the elderly, diuretic-based treatment studies have been clearly shown to prevent major cardiovascular events, including stroke, heart failure and coronary heart disease.
引用
收藏
页码:S15 / S22
相关论文
共 50 条
  • [41] Prevention of falls in the elderly
    Myers, AH
    Young, Y
    Langlois, JA
    BONE, 1996, 18 (01) : S87 - S101
  • [42] Secondary prevention in the elderly
    Smith, SC
    CORONARY ARTERY DISEASE, 1998, 9 (11) : 715 - 718
  • [43] Fall prevention in the elderly
    Ungar, Andrea
    Rafanelli, Martina
    Iacomelli, Iacopo
    Brunetti, Maria Angela
    Ceccofiglio, Alice
    Tesi, Francesca
    Marchionni, Niccolo
    CLINICAL CASES IN MINERAL AND BONE METABOLISM, 2013, 10 (02) : 91 - 95
  • [44] Colchicine and cardiovascular prevention
    Alunno, Alessia
    Carubbi, Francesco
    Ferri, Claudio
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2024, 121 : 30 - 34
  • [45] Prevention in cardiovascular pathology
    Chamontin, B
    Amar, J
    THERAPIE, 2001, 56 (02): : 119 - 124
  • [46] Management of hypertension in the elderly: Looking for a trade-off between cardiovascular prevention and serious adverse events
    Buonacera, Agata
    Stancanelli, Benedetta
    Malatino, Lorenzo
    MONALDI ARCHIVES FOR CHEST DISEASE, 2018, 88 (02) : 44 - 46
  • [47] Long-term Cost-effectiveness of Statin Treatment for Primary Prevention of Cardiovascular Disease in the Elderly
    Liang Lin
    Monica Teng
    Ying Jiao Zhao
    Ai Leng Khoo
    Raymond Chee Seong Seet
    Quek Wei Yong
    Tiong Cheng Yeo
    Boon Peng Lim
    Cardiovascular Drugs and Therapy, 2015, 29 : 187 - 197
  • [48] Long-term Cost-effectiveness of Statin Treatment for Primary Prevention of Cardiovascular Disease in the Elderly
    Lin, Liang
    Teng, Monica
    Zhao, Ying Jiao
    Khoo, Ai Leng
    Seet, Raymond Chee Seong
    Yong, Quek Wei
    Yeo, Tiong Cheng
    Lim, Boon Peng
    CARDIOVASCULAR DRUGS AND THERAPY, 2015, 29 (02) : 187 - 197
  • [49] Possibilities of multifactorial cardiovascular disease prevention in patients aged 75 and older: a randomized controlled trial - Drugs and Evidence Based Medicine in the Elderly (DEBATE) Study
    Strandberg, TE
    Pitkala, K
    Berglind, S
    Nieminen, MS
    Tilvis, RS
    EUROPEAN HEART JOURNAL, 2003, 24 (13) : 1216 - 1222
  • [50] Cardiovascular drugs and the elderly.
    Grand, A
    ANNALES DE CARDIOLOGIE ET D ANGEIOLOGIE, 1997, 46 (07): : 461 - 468